OncoSenX
OncoSenX is a spinout company of Oisin Biotechnologies, formed to develop programmable suicide gene therapy to kill cancerous cells.
5
Funding Rounds
$19.7m
Money raised
Overview
OncoSenX is a spinout company of Oisin Biotechnologies, formed to develop programmable suicide gene therapy to kill cancerous cells.
-
Website:
- Business model: B2C B2B
- Social accounts:
Funding series
Funding Series Analysis
The company OncoSenX has raised a total of $3m in funding over 5 rounds.
Key Insights:
- OncoSenX , July 2019: $3m
- OncoSenX Pre Seed Funding Round July 2019: $3m
- OncoSenX Pre Seed Funding Round April 2020: $4.5m
- OncoSenX, Inc. funding round, August 2021: $5m
- OncoSenX Grant July 2020: $4.2m
OncoSenX , July 2019
$3m
OncoSenX, Inc. funding round, August 2021
$5m
OncoSenX Pre Seed Funding Round July 2019
$3m
OncoSenX Pre Seed Funding Round April 2020
$4.5m
OncoSenX Grant July 2020
$4.2m
Industries
OncoSenX is active in the following industries: